Feature | August 28, 2013

Zilver PTX Drug-Eluting Peripheral Qualifies for Additional Medicare Reimbursement

August 28, 2013 — Effective Oct. 1, Cook Medical’s Zilver PTX drug-eluting peripheral stent qualifies for new-technology add-on payments under Medicare’s hospital inpatient prospective payment system.

“This is great news for Medicare beneficiaries who suffer from peripheral arterial disease, and for U.S. hospitals that treat these patients,” said Jim Gardner, M.D., director of reimbursement and medical science officer for Cook Medical.

Zilver PTX technology had to meet three criteria to qualify for add-on reimbursement. First, a new technology must represent a substantial clinical improvement. Second, the data that Medicare uses to set payments for the new technology under the Medicare severity diagnosis-related groups (MS-DRGs) must not be available. Third, the MS-DRG payment rate that otherwise applies to the new technology must be inadequate.

The add-on reimbursement typically remains in place two to three years, at which point Medicare will determine the “permanent” diagnosis-related group assignments for Zilver PTX procedures, Gardner added. While the add-on payment is in effect, hospitals can receive up to $1,705.25 in additional reimbursement for each patient that is treated on an inpatient basis with Zilver PTX stents.

“Now that Medicare has recognized the benefits of this technology, we encourage our hospital customers to discuss similar reimbursement policies with the commercial insurance plans they contract with,” Gardner said.

This additional reimbursement is available to hospitals only for inpatient procedures. It doesn’t affect physician reimbursement, hospital reimbursement for outpatient procedures, or ambulatory surgery center (ASC) reimbursement for Zilver PTX stenting procedures performed in the ASC.

For more information: www.cookmedical.com

Related Content

News | Cath Lab| October 09, 2015
October 9, 2015 — Cardinal Health is launching its expanded portfolio in the cardiova
Shimadzu, MIX package, Trinias Cardiovascular suites, U.S. availability

Image courtesy of Shimadzu Medical Systems

Technology | Cath Lab| October 08, 2015
Shimadzu Medical Systems USA announced the availability of the MIX package for the Trinias Cardiovascular suites. Based...
ORSIF, radiation exposure for interventionalists, greater on left side of head, Ehtisham Mahmud
Feature | Radiation Dose Management| October 06, 2015
The results of a research study indicate that interventional cardiologists receive “very high” radiation exposure...
Synergy stent
Technology | October 05, 2015
October 5, 2015 — The U.S.
Tryton Side Branch Stent, clinical trial results, Catheterization and Cardiovascular Interventions

Tryton Side Branch Stent image courtesy of Tryton Medical

News | Stents Bifurcation| October 02, 2015
October 2, 2015 — Tryton Medical Inc.
Brilinta, 60 mg dose available, U.S. pharmacies
Technology | Antiplatelet and Anticoagulation Therapies| October 02, 2015
AstraZeneca announced that Brilinta (ticagrelor) 60-mg tablets are now available in U.S. pharmacies. On Sept. 3, 2015,...
Intact Vascular, TOBA II study, Tack Endovascular System

Image courtesy of Intact Vascular

News | Peripheral Arterial Disease (PAD)| October 01, 2015
Intact Vascular Inc. announced the U.S. Food and Drug Administration has granted conditional approval for a U.S. and...
Cook Medical, Zilver PTX, Japan PMS study, CIRSE 2015, two-year results

Image courtesy of Cook Medical

News | Stents Peripheral| October 01, 2015
Kimihiko Kichikawa, M.D., department of radiology at Nara Medical University in Japan, reported two-year results of the...
Stentys, CE Mark for self-apposing stent, lower limb artery disease, below-the-knee arteries, critical limb ischemia, PES BTK-70 trial

Image courtesy of Stentys

News | Stents Peripheral| October 01, 2015
Stentys announced that the company’s drug-eluting stent received CE Mark for treatment of below-the-knee (BTK) arteries...
raysafe, i2, staff dose monitoring
News | Radiation Dose Management| October 01, 2015
October 1,2015 — The first and only system that delivers real-time X-ray radiation dose monitoring for physicians and
Overlay Init